(Q48465568)

11 February 2018

title

No evidence or no alternative? Taking responsibility for off-label prescribing. (English)

1 reference

11 February 2018

author

Richard O. Day

4

1 reference

11 February 2018

author name string

N Ghinea

1

1 reference

11 February 2018

W Lipworth

2

1 reference

11 February 2018

I Kerridge

3

1 reference

11 February 2018

publication date

1 March 2012

1 reference

11 February 2018

Internal Medicine Journal

published in

1 reference

11 February 2018

volume

42

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

247-251

1 reference

11 February 2018

Going off-label without venturing off-course: evidence and ethical off-label prescribing.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

The promotion of olanzapine in primary care: an examination of internal industry documents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Off-label prescribing: a call for heightened professional and government oversight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Off-label prescribing among office-based physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Off-label use of second-generation antipsychotic agents among elderly nursing home residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Off-label prescribing to children in the United States outpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Treatment of traumatic bleeding with recombinant factor VIIa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Variation in the use of recombinant activated factor VII in critical bleeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

A hemorrhage of off-label use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2012.02713.X

10.1111/J.1445-5994.2012.02713.X

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

22432984

1 reference

11 February 2018